Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic

Firinu D.;del Giacco S.;
2020-01-01

2020
Benralizumab; Covid-19; Dupilumab; Mepolizumab; Omalizumab; Reslizumab; SARS-CoV-2; Telemedicine
Files in This Item:
File Size Format  
Klimek2020_Article_AnwendungVonBiologikaBeiAllerg.pdf

Solo gestori archivio

Type: versione editoriale
Size 820.39 kB
Format Adobe PDF
820.39 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie